🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-arm, multi-center, phase II exploratory study...
Status
Unknown
Location
Zhou Chengzhi
Start Date
2020-04-01
Trial ID
NCT04316351
Treatments Being Tested
Anlotinib is a novel oral multitarget tyrosine kinase inhibitor and primary...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2019-04-30
Trial ID
NCT04012619
Treatments Being Tested
This study will compare maintenance therapy with anlotinib plus pemetrexed ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-07-01
Trial ID
NCT04453423
Treatments Being Tested
In recent years, with the progress in the treatment field, Non-Small Cell L...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2019-03-22
Trial ID
NCT03790228
Treatments Being Tested
The purpose of this clinical study is to evaluate the tolerability and toxi...
Status
Unknown
Location
Multiple Locations
Start Date
2018-07-01
Trial ID
NCT03566576
Treatments Being Tested
Non-small cell lung cancer has the highest morbidity and mortality in China...
Status
Unknown
Location
Multiple Locations
Start Date
2018-08-15
Trial ID
NCT03636685
This is a phase III , randomized, double-blinded, multicenter clinical stud...
Status
Terminated
Location
Chinese PLA General Hospital
Start Date
2018-11-27
Trial ID
NCT03866980
Treatments Being Tested
Evaluate the efficacy and safety of Anlotinib plus Pemetrexed as the 1-line...
Status
Unknown
Location
Beijing Chest Hospital
Start Date
2018-11-26
Trial ID
NCT03768037
Treatments Being Tested
In recent years, with the progress in the treatment field, NSCLC has become...
Status
Unknown
Location
Henan Provincial People's Hospital
Start Date
2019-01-01
Trial ID
NCT03778138
Treatments Being Tested
This is a Phase II, prospective, randomized, open label, controlled, multi-...
Status
Not Yet Recruiting
Location
Tangdu Hospital of the Fourth Millitary Medical University
Start Date
2024-06-30
Trial ID
NCT06475755
Treatments Being Tested